Kaynak: Zacks Investment Research
Haber Ajansı
Hisse Senedi
Orta Önem

Can Acadia (ACAD) Run Higher on Rising Earnings Estimates?
Acadia Pharmaceuticals (ACAD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
İlgili Semboller
1
A
ACAD
ACAD
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et